During a period when macroeconomic variables and geopolitical events seem to be driving so much of equity returns, it can be tempting to try to forecast what happens next. Good luck with that.
Out of Our Minds
Portfolio manager and analyst Wenting Shen braved China’s Zero-COVID policy to reconnect in person with her portfolio investments—and her family. This is what she encountered.
Anecdotal reports from the companies we follow indicate differing impacts from rising prices—and offer a few clues to where inflation is headed.
The country’s recent wave of changes may not be quite as unprecedented as it seems.
Recent changes in the regulatory environment in China have sparked questions and discussions about the future of investing in the country, both in the wider world and inside Harding Loevner.
Which industry is in the best position to deliver better care at more reasonable prices? It depends on whom you ask.
Just months after the GameStop episode, the impact of the infamous retail-investor-led short squeeze has faded like a bad dream. Or has it?
For investors today, one of the hardest jobs has become knowing what to ignore.
A frank assessment of what vaccine production and distribution delays—and concerning data about new COVID-19 variants—mean for the rest of 2021 and beyond.
Lewis Carroll’s Alice in the Wonderland can seem the perfect metaphor for a market trading at record valuations amid a global pandemic. But the most insightful perspective may come from a line in the movie.
Before everyone knew them as “factors,” quality, growth, and value indications were the way we identified good companies, in a way that fit our personalities.